QUOTED. 5 January. Jennifer Meade.
Hologic Inc. said the buy-out of Somatex Medical Technologies GmbH for about $64m will allow it to strengthen and further expand its breast cancer marker portfolio and expand sales in Europe. See what Jennifer Meade, Hologic’s division president, breast and skeletal health solutions, said about it here.
“The acquisition of Somatex allows us to expand our biopsy portfolio by providing a suite of market-leading solutions that not only address our customers’ needs, but also improve the biopsy experience for their patients.” – Jennifer Meade, division president, breast and skeletal health solutions, Hologic
- Find out more: Hologic Acquires Somatex Medical For $64M To Expand Breast Health Care, European Sales Presence
Click here for a free trial of Medtech Insight